CWM
IONS icon

Circle Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Circle Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-22,500
Closed -$1.27M – 186
2020
Q4 		$1.27M Hold
22,500
– – 0.18% 69
2020
Q3 		$1.07M Hold
22,500
– – 0.18% 63
2020
Q2 		$1.33M Sell
22,500
-5,400
-19% -$300K 0.23% 47
2020
Q1 		$1.32M Sell
27,900
-3,250
-10% -$181K 0.26% 48
2019
Q4 		$1.88M Hold
31,150
– – 0.33% 36
2019
Q3 		$1.87M Sell
31,150
-1,100
-3% -$71.7K 0.4% 31
2019
Q2 		$2.07M Sell
32,250
-7,400
-19% -$523K 0.45% 31
2019
Q1 		$3.22M Buy
+39,650
New +$2.56M 0.72% 17

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Circle Wealth Management's IONS Position: Q1 2021 in Review

Circle Wealth Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2021, closing a stake of 22,500 shares — an estimated $1.27M sold.

Circle Wealth Management first reported a position in IONS in Q1 2019 and held it in 8 quarters. The position peaked at $3.22M in Q1 2019. 364 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

  • Circle Wealth Management reported no remaining Ionis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Circle Wealth Management sold 22,500 Ionis Pharmaceuticals shares in Q1 2021, an estimated $1.27M.
  • Circle Wealth Management first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 8 quarters.
  • Circle Wealth Management's Ionis Pharmaceuticals position peaked at $3.22M in Q1 2019.
  • 364 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on Circle Wealth Management's 13F filing for Q1 2021, filed 17 May 2021.